Professor Jacob George
Chair of Cardiovascular Medicine and Therapeutics, Cardiology
Cardiovascular Research, School of Medicine

Contact
Biography
Professor Jacob George is Professor of Cardiovascular Medicine & Therapeutics at the University of Dundee Medical School. Professionally, he is a Consultant Physician qualified in Clinical Pharmacology and General Internal Medicine and is an accredited European Hypertension Specialist. He is a Fellow of the Royal College of Physicians Edinburgh, European Society of Cardiology and the British Hypertension Society. Professor George is visiting Professor at the Dnipro State Medical University, Ukraine. His clinical interest is in managing patients with high Cardiovascular risk and he is Clinical Lead for the Cardiovascular Risk Service in NHS Tayside. His research interests are focused on managing cardiovascular risk factors such as left ventricular hypertrophy, salt and smoking/vaping. His research publications have been covered by more than 50 news organizations worldwide and he has conducted more than 80 media interviews including live television broadcasts to national and international media on the results of his research.
He is actively involved in Medicines Governance in the UK being the Chair of the Scottish Government Access to New Medicines, Horizon Scanning Advisory Board (HSAB), National Clinical Lead for the Scottish Medicines Consortium. He sits on the Steering Group of the Innovative Licensing and Access Pathway (ILAP), a joint initiative between the MHRA, NICE,SMC and AWTTC. He is the current Co-Chair on the National Institutes of Health Research (NIHR) Capital Investment Funding Committee (2024-2027). He has been Senior Health Technology Advisor to NICE. Locally, he is Chair of the Medicines Advisory Group and is a member of the PACS Tier 2 Committee. He was recently appointed by the Minister of Health, Malaysia as an International Expert Advisory Member of the Malaysian Scientific Review Panel for Phase I Clinical Trials.
In addition to these roles, he is also Clinical Advisor to PhaSER Biomedical Ltd, a newco focused on delivering safe and effective drugs in the real world.
Media availability
I am available for media commentary on my research.
Professor George is an expert in regulatory medicine, health technology assessments, drug development, clinical trials. His clinical speciality is Cardiovascular Risk Management, specifically in Hypertension and Lipid management.
Contact Corporate Communications for media enquiries.
Areas of expertise
- Heart disease
- Medicines
- Smoking and vaping
- Cholesterol Management
- High Blood Pressure
Stories
Press release
Staff and students from the University of Dundee have had their achievements recognised in the Scottish Parliament.

Press release
The potential health effects of passive vaping are to be explored for the first time as part of an important new Scottish research study.

Press release
A Dundee team who developed an innovative app that supports healthcare providers to prescribe opioids safely to patients receiving palliative care have received a top award
